Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 2
2009 1
2011 4
2012 4
2013 7
2014 5
2015 8
2016 8
2017 9
2018 10
2019 6
2020 9
2021 8
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate.
Fiala O, Hošek P, Korunková H, Hora M, Kolář J, Šorejs O, Topolčan O, Filipovský J, Liška V, Santoni M, Buti S, Fínek J. Fiala O, et al. Among authors: finek j. Cancer Med. 2024 Jan 2;13(1):e6853. doi: 10.1002/cam4.6853. Online ahead of print. Cancer Med. 2024. PMID: 38164124 Free PMC article.
Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience.
Fiala O, Hosek P, Korunkova H, Hora M, Kolar J, Windrichova J, Sorejs O, Topolcan O, Travnicek I, Sedlackova H, Finek J. Fiala O, et al. Among authors: finek j. Anticancer Res. 2023 Jan;43(1):463-471. doi: 10.21873/anticanres.16183. Anticancer Res. 2023. PMID: 36585174
Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study.
Fiala O, Baxa J, Svaton M, Benesova L, Ptackova R, Halkova T, Minarik M, Hosek P, Buresova M, Finek J, Ferda J, Pesek M. Fiala O, et al. Among authors: finek j. Cancer Genomics Proteomics. 2022 Mar-Apr;19(2):270-281. doi: 10.21873/cgp.20319. Cancer Genomics Proteomics. 2022. PMID: 35181593 Free PMC article.
Molecular testing in endometrial carcinoma (Joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists).
Dundr P, Cibula D, Doležel M, Fabian P, Fínek J, Jirásek T, Matěj R, Luboš, Petruželka, Rob L, Ryška A, Švajdler M, Weinberger V, Zikán M. Dundr P, et al. Among authors: finek j. Cesk Patol. 2021 Summer;57(3):181-187. Cesk Patol. 2021. PMID: 34551568 English.
Molecular testing in endometrial carcinoma - joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists.
Dundr Pavel, Cibula David, Doležel Martin, Fabián Pavel, Fínek Jindřich, Jirásek Tomáš, Matěj Radoslav, Petruželka Luboš, Rob Lukáš, Ryška Aleš, Švajdler Marián, Weinberger Vít, Zikán Michal. Dundr Pavel, et al. Among authors: finek jindrich. Ceska Gynekol. 2021;86(4):264-272. doi: 10.48095/cccg2021264. Ceska Gynekol. 2021. PMID: 34493052 English.
82 results